Euclidean Capital

Euclidean Capital as of Dec. 31, 2022

Portfolio Holdings for Euclidean Capital

Euclidean Capital holds 11 positions in its portfolio as reported in the December 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ishares Tr Msci India Etf (INDA) 22.5 $24M 577k 41.74
23andme Holding Class A Com (ME) 20.7 $22M 10M 2.16
Pmv Pharmaceuticals (PMVP) 19.0 $20M 2.3M 8.70
Alector (ALEC) 8.5 $9.1M 981k 9.23
Rapt Therapeutics (RAPT) 8.0 $8.6M 433k 19.80
Foghorn Therapeutics (FHTX) 7.5 $8.0M 1.3M 6.38
Oric Pharmaceuticals (ORIC) 4.1 $4.4M 748k 5.89
First Financial Ban (FFBC) 3.9 $4.2M 174k 24.23
Ngm Biopharmaceuticals 3.5 $3.7M 747k 5.02
Tenaya Therapeutics (TNYA) 1.7 $1.8M 916k 2.01
Surrozen 0.4 $467k 803k 0.58